Literature DB >> 8182956

Mathematical model of cardiovascular mechanics for diagnostic analysis and treatment of heart failure: Part 2. Analysis of vasodilator therapy and planning of optimal drug therapy.

H Tsuruta1, T Sato, N Ikeda.   

Abstract

Using a mathematical model of cardiovascular mechanics, various complicated responses to vasodilator therapy for heart failure have been well accounted for through common logic: (i) the differential effects of various vasodilators on cardiac output; (ii) the opposite response of cardiac output to sodium nitroprusside in a normal state and heart failure state; (iii) the different responses of cardiac index, arterial pressure and left ventricular end-diastolic pressure to hydralazine in different types of heart failure. The response to combined vasodilator-inotropic agent therapy was simulated well by the model. The optimal therapeutic regimen was then formulated to simultaneously control the cardiac output, systemic and pulmonary arterial and venous pressures, and the degree of coronary ischaemia by multiple drug delivery, and the problem was solved using the model. We conclude that the model provides a useful basis for obtaining a guidance for more appropriate therapeutic regimen in heart failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182956     DOI: 10.1007/bf02512473

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  17 in total

1.  Automatic control of blood pressures with multiple drug inputs.

Authors:  B C McInnis; L Z Deng
Journal:  Ann Biomed Eng       Date:  1985       Impact factor: 3.934

2.  Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure.

Authors:  H Pouleur; J W Covell; J Ross
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

3.  Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure.

Authors:  M Packer; J Meller; N Medina; R Gorlin; M V Herman
Journal:  N Engl J Med       Date:  1980-07-31       Impact factor: 91.245

Review 4.  Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.

Authors:  D T Mason
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

5.  A circulatory model for combined nitroprusside-dopamine therapy in acute heart failure.

Authors:  C Yu; R J Roy; H Kaufman
Journal:  Med Prog Technol       Date:  1990-05

6.  Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

Authors:  C V Leier; P T Heban; P Huss; C A Bush; R P Lewis
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

7.  Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.

Authors:  D R Stemple; J H Kleiman; D C Harrison
Journal:  Am J Cardiol       Date:  1978-08       Impact factor: 2.778

8.  Selection of vasodilator, inotropic or combined therapy for the management of heart failure.

Authors:  J N Cohn; J A Franciosa
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

9.  Resistance and volume changes caused by nitroprusside in the dog.

Authors:  S A Rubin; G Misbach; J Lekven; W W Parmley; J V Tyberg
Journal:  Am J Physiol       Date:  1979-07

10.  Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction.

Authors:  R R Miller; N A Awan; J A Joye; K S Maxwell; A N DeMaria; E A Amsterdam; D T Mason
Journal:  Circulation       Date:  1977-06       Impact factor: 29.690

View more
  4 in total

1.  Mathematical model of cardiovascular mechanics for diagnostic analysis and treatment of heart failure: Part 1. Model description and theoretical analysis.

Authors:  H Tsuruta; T Sato; M Shirataka; N Ikeda
Journal:  Med Biol Eng Comput       Date:  1994-01       Impact factor: 2.602

2.  Closing the loop: modelling of heart failure progression from health to end-stage using a meta-analysis of left ventricular pressure-volume loops.

Authors:  David R Warriner; Alistair G Brown; Susheel Varma; Paul J Sheridan; Patricia Lawford; David R Hose; Abdallah Al-Mohammad; Yubing Shi
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

3.  Effects of Pulsatile Frequency of Left Ventricular Assist Device (LVAD) on Coronary Perfusion: A Numerical Simulation Study.

Authors:  Yuanfei Zhu; Ming Yang; Yan Zhang; Fan Meng; Tianyue Yang; Zhiwei Fang
Journal:  Med Sci Monit       Date:  2020-09-17

4.  Fast parameters estimation in medication efficacy assessment model for heart failure treatment.

Authors:  Yinzi Ren; Xiao Fu; Qing Pan; Chengyu Lin; Guiqiu Yang; Li Li; Shijin Gong; Guolong Cai; Jing Yan; Gangmin Ning
Journal:  Comput Math Methods Med       Date:  2012-10-03       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.